rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Guardian Pharmacy Services, Inc.

GRDN · NYSE

Consumer StaplesMass, Grocery & Drug RetailJust dropped out

GRDN stood above a rising 150-day average in 51 of the last 52 weekly readings, and has been out of that trend for the last 1 week. It is 1.7% below that average now. Mass, Grocery & Drug Retail: 39% of its 26 stocks in an uptrend (+8 points in four weeks); Consumer Staples: 25% (+4 points in four weeks).

Statistics

Rotation
Just dropped out
Weeks in an uptrend
out for 1
Industry in uptrend
39% +8 in 4 wk
Insider buys, 12 months
$100K
Insider sales, 12 months
$838.5M
Officials’ trades on record
0
Institutions holding
178 (+18)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 51 of 52 weeks.

22 Apr – 21 Oct
18%35%52%Apr 26Jun 26Jul 26Sep 26Oct 26

Mass, Grocery & Drug Retail: A minority of its stocks are in an uptrend and the share has been climbing. Consumer Staples: A minority of its stocks are in an uptrend and the share has been climbing.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$808.3M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months1
Sale orders, 12 months9
Buyers · sellers1 · 9
WhoDidSharesTraded
Cardinal Equity Fund, L.p.Othersold275,728at $29.6820 Mar 2026filed 24 Mar 2026
Kendall ForbesOfficersold346,672at $29.6820 Mar 2026filed 24 Mar 2026
William E. BindleyDirector, 10% ownersold3,570,677at $29.6820 Mar 2026filed 24 Mar 2026
John AckermanDirectorsold827,636at $29.6820 Mar 2026filed 24 Mar 2026
John AckermanDirectorsold275,728at $29.6820 Mar 2026filed 24 Mar 2026
Bindley Capital Partners I, Llc10% ownersold3,570,677at $29.6820 Mar 2026filed 24 Mar 2026
Thomas J. Salentine, Jr.Director, 10% ownersold3,570,677at $29.6820 Mar 2026filed 24 Mar 2026
Fred BurkeDirector, Officersold671,432at $29.6820 Mar 2026filed 24 Mar 2026
Pharmacy Investors, LlcOthersold827,636at $29.6820 Mar 2026filed 24 Mar 2026
David K. MorrisDirector, Officersold187,855at $29.6820 Mar 2026filed 24 Mar 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders178+18 on the quarter
New · exited36 · 17
Reported value$1.1B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
FMR LLCadded · filed 13 Aug 20263,241,612$135.7M+882,255+37.4%
WELLINGTON MANAGEMENT GROUP LLPreduced · filed 14 Aug 20261,729,032$72.4M-36,087−2.0%
BlackRock, Inc.reduced · filed 7 Aug 20261,575,989$66.0M-180,385−10.3%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 20261,379,750$57.8M+154,207+12.6%
Woodline Partners LPadded · filed 14 Aug 20261,306,340$54.7M+220.0%
Valiant Capital Management, L.P.unchanged · filed 14 Aug 20261,186,658$49.7M00.0%
Boston Partnersreduced · filed 4 Aug 2026983,868$40.8M-33,815−3.3%
FRANKLIN RESOURCES INCadded · filed 13 Aug 2026966,206$40.5M+13,254+1.4%
TimesSquare Capital Management, LLCreduced · filed 7 Aug 2026951,637$39.8M-125,837−11.7%
LOOMIS SAYLES & CO L Preduced · filed 14 Aug 2026869,836$36.4M-61,853−6.6%
30 Sep 2024 – 30 Jun 2026
49111173Sep 24Mar 25Sep 25Dec 25Jun 26

News

No headline names it lately.

Everyone who traded it

Bindley Capital Partners I, LLC Company insider10% owner, Other · last 27 Sep 20260 · 3
Cardinal Equity Fund, L.P. Company insiderOther · last 27 Sep 20260 · 3
Chris Crisafulli Company insiderOfficer · last 27 Sep 20260 · 0
David K. Morris Company insiderDirector, Officer, Other · last 27 Sep 20260 · 3
David Norman Martin Company insiderOfficer · last 27 Sep 20260 · 0
Douglas Towns Company insiderOfficer · last 27 Sep 20260 · 0
Fred Burke Company insiderDirector, Officer, Other · last 27 Sep 20260 · 3
Jeffrey Tuch Company insiderOfficer · last 27 Sep 20260 · 0
John Ackerman Company insiderDirector, Other · last 27 Sep 20260 · 3
Kendall Forbes Company insiderOther · last 27 Sep 20260 · 3
Pharmacy Investors, LLC Company insiderOther · last 27 Sep 20260 · 3
Richard Eakins Company insiderSenior Vice President, Sales · last 27 Sep 20260 · 0

Same industry

TBBB BBB FoodsLeading+36%
TGT TargetLeading+10%
BJ BJ's Wholesale Club HoldingsJust started moving+10%
WMK Weis MarketsJust started moving+3%
FIVE Five BelowJust started moving+2%
CVS CVS HealthJust started moving+2%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202520.2%
Operating profit marginFY 2025 · to 31 Dec 20255.0%
Free cash flow marginFY 2025 · to 31 Dec 20256.0%
Return on capital employedFY 2025 · to 31 Dec 202528.9%
Cash conversionFY 2025 · to 31 Dec 2025204%
Cash and equivalentsFY 2025 · to 31 Dec 2025$65.6M
Free cash flowFY 2025 · to 31 Dec 2025$86.8M

Analyst forecasts

No analyst forecasts yet.